Drug Patents owned by Aurinia

1. Drug name - LUPKYNIS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7332472 AURINIA Cyclosporine analogue mixtures and their use as immunomodulating agents
Oct, 2022

(14 days from now)

CN101353810B AURINIA For Semiconductor Wafer Cleaning Method And Device
Mar, 2019

(3 years ago)

CN1653211A AURINIA Electropolishing And/Or Electroplating Apparatus And Method
Mar, 2019

(3 years ago)

CN100430526C AURINIA Electropolishing And/Or Electroplating Apparatus And Method
Mar, 2019

(3 years ago)

CN101353810A AURINIA Electropolishing And/Or Electroplating Apparatus And Methods
Mar, 2019

(3 years ago)

CN100344648C AURINIA Cyclosporine Analogue Mixtures And Their Use In Preparation Of Immunomodulator
Oct, 2022

(14 days from now)

CN100334106C AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

CN1571794A AURINIA Cyclosporine Analogue Mixtures And Their Use As Immunomodulating Agents
Oct, 2022

(14 days from now)

CN1571795A AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

CN1274294C AURINIA Cyclosporin Analog Microemulsion Preconcentrates
Oct, 2022

(14 days from now)

CN1571657A AURINIA Novel Cyclosporin Analog Microemulsion Preconcentrates
Oct, 2022

(14 days from now)

CN100497748C AURINIA Polishing Component And The Conductive Layer To Perform Electrolytic Polishing Method
Nov, 2022

(a month from now)

CN1585835A AURINIA Polishing Assembly And The Conductive Layer Is Subjected To Electrolytic Polishing Method
Nov, 2022

(a month from now)

IN201105103P1 AURINIA Method Of Producing An E-Isomer And A Z-Isomer
Oct, 2022

(14 days from now)

IN200400693P1 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

IN304347B AURINIA Method Of Producing An E-Isomer And A Z-Isomer
Oct, 2022

(14 days from now)

IN256418B AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

EP1436321B9 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

EP1436321A2 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

EP1436321B1 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

EP1435910B1 AURINIA Novel Cyclosporin Analog Microemulsion Preconcentrates
Oct, 2022

(14 days from now)

EP1436322A2 AURINIA Cyclosporine Analogue Mixtures And Their Use As Immunomodulating Agents
Oct, 2022

(14 days from now)

EP1714977A3 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

EP1714977A2 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

EP1436322B1 AURINIA Cyclosporine Analogue Mixtures And Their Use As Immunomodulating Agents
Oct, 2022

(14 days from now)

EP1435910A1 AURINIA Novel Cyclosporin Analog Microemulsion Preconcentrates
Oct, 2022

(14 days from now)

EP1435910B9 AURINIA Novel Cyclosporin Analog Microemulsion Preconcentrates
Oct, 2022

(14 days from now)

EP1714977B1 AURINIA Synthesis Of Cyclosporin Analogs
Oct, 2022

(14 days from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10286036 AURINIA Protocol for treatment of lupus nephritis Dec, 2037

(15 years from now)

Drugs and Companies using VOCLOSPORIN ingredient

Treatment: Treatment of patients with active lupus nephritis

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
7.9MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.